- Home
- SNY vs SPGI Comparison
SNY vs SPGI Comparison
Compare SNY & SPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- SPGI
- Stock Information
- Founded
- SNY 1994
- SPGI 1860
- Country
- SNY France
- SPGI United States
- Employees
- SNY N/A
- SPGI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- SPGI Finance: Consumer Services
- Sector
- SNY Health Care
- SPGI Finance
- Exchange
- SNY Nasdaq
- SPGI Nasdaq
- Market Cap
- SNY 127.5B
- SPGI 150.8B
- IPO Year
- SNY N/A
- SPGI N/A
- Fundamental
- Price
- SNY $47.85
- SPGI $510.41
- Analyst Decision
- SNY Buy
- SPGI Buy
- Analyst Count
- SNY 2
- SPGI 14
- Target Price
- SNY $57.50
- SPGI $581.25
- AVG Volume (30 Days)
- SNY 2.3M
- SPGI 1.3M
- Earning Date
- SNY 10-25-2024
- SPGI 10-24-2024
- Dividend Yield
- SNY 4.27%
- SPGI 0.72%
- EPS Growth
- SNY N/A
- SPGI 46.60
- EPS
- SNY 4.00
- SPGI 11.32
- Revenue
- SNY $54,031,898,261.00
- SPGI $13,768,000,000.00
- Revenue This Year
- SNY $3.18
- SPGI $14.61
- Revenue Next Year
- SNY $6.67
- SPGI $6.37
- P/E Ratio
- SNY $23.82
- SPGI $44.48
- Revenue Growth
- SNY 6.01
- SPGI 12.10
- 52 Week Low
- SNY $45.22
- SPGI $407.69
- 52 Week High
- SNY $58.97
- SPGI $533.29
- Technical
- Relative Strength Index (RSI)
- SNY 24.92
- SPGI 53.26
- Support Level
- SNY $47.46
- SPGI $496.13
- Resistance Level
- SNY $48.67
- SPGI $515.80
- Average True Range (ATR)
- SNY 0.68
- SPGI 8.66
- MACD
- SNY -0.26
- SPGI 1.51
- Stochastic Oscillator
- SNY 4.43
- SPGI 75.23
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.